Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
-1.85%
-2.66$
140.96$
20:24 11/12/17
140.96$
20:24 11/12/17
DAILY VARIATION
-1.85%
-2.66$
VOLUME
851,912
DATA
52 Week High
166.11$
52 Week Low
72.02$
Shares Issued
252.90m
Market Cap
$35,647.92m
RiskGrade
136
Beta
1.05
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 0.6% 20.7%
ROCE 0.0%
Latest F'cast
P/E -312.2 7,679.7
PEG 0.0 -999,999.0
Pr/Revenue 21.3 17.0
Pr/Book 27.1
Latest F'cast
Revenue 64.9% -4.9%
PBT 0.0% n/a
EPS 0.0% -20.2%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 -314.00¢ -37.8 0.0 n/a n/a 0.0%
2015-12-31 1,032.34 -557.80 -231.00¢ -54.5 0.0 n/a n/a 0.0%
2016-12-31 1,702.18 -67.37 -46.00¢ -160.2 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 2,133.68 441.12 188.53c 7,679.7 n/a 0% 0.00c 0.0%
2018-12-31 2,741.33 772.32 291.88c 4,787.0 87.3 55% 0.00c 0.0%

Regulatory News

No results found

Newspaper Links

No results found